Clinical Trials in Nashville

Showing 1261-1280 of 9,711 trials

A Study of Select Drug Combinations in Adult Patients With Advanced/Metastatic BRAF V600 Colorectal Cancer

NCT04294160

A phase Ib, open-label platform study of select drug combinations chosen in order to characterize safety and tolerability of each treatment arm tested and to identify recommended doses and regimens for future studies.

BRAF V600 Colorectal Cancer

Novartis Pharmaceuticals122 participantsStarted Jul 2020

Los Angeles, California, United States • Boston, Massachusetts, United States • Nashville, Tennessee, United States +15 more locations

ACTIVE_NOT_RECRUITINGPHASE4< 1 mile

The Impact of Factor Xa Inhibition on Thrombosis, Platelet Activation, and Endothelial Function in Peripheral Artery Disease

NCT05009862

The purpose of this study is to understand how the drug rivaroxaban improves symptoms associated with peripheral artery disease.

Peripheral Arterial Disease

Vanderbilt University Medical Center75 participantsStarted Apr 2022

Nashville, Tennessee, United States

A Study of Select Drug Combinations in Adult Patients With Advanced/Metastatic BRAF V600 Colorectal Cancer

The Impact of Factor Xa Inhibition on Thrombosis, Platelet Activation, and Endothelial Function in Peripheral Artery Disease

Find Trials by Condition in Nashville

Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease

A Study of YL242 in Subjects With Advanced Solid Tumors

Prevention of Colorectal Cancer Through Multiomics Blood Testing

A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

Observational Study Protocol: LIVER-R

Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL

Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029)

A Study of HBI-8000 (Tucidinostat) With Pembrolizumab in Non-Small Cell Lung Cancer

Clinical and Molecular Studies in Families With Inherited Eye Disease

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

SPI-1005 for the Treatment of Meniere's Disease (Open Label)

A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma

Optimizing a Sensor-Enabled mHealth Intervention for Adolescents With Suboptimal Asthma Control

Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD

Tensi+ for Treating Overactive Bladder: A Randomized Controlled Trial

An Observational Study of Patients With Moderate Parkinson's Disease

A Study of DM919 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors